Epistemic AI

AI for biomedical discovery

Westport, Connecticut, United States

Drug Discovery/Development AI / MLUnknown

Platform used by Division of Pulmonary Medicine at Cincinnati Children's Hospital for augmentation and acceleration of research in Cystic Fibrosis and respiratory disease.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Epistemic AI on @MedStartr Today Platform used by Division of Pulmonary Medicine at Cincinnati Children's Hospital for augmentation and acceleration of research in Cystic Fibrosis and respiratory disease. #CysticFibrosis #MentalBehavioralHealth #RespiratoryDiseases #DrugDiscoveryDevelopment #AIML #MedMo #MedStartrVentures

https://www.medstartr.ai/s/gzlamZDYzUg

Get Involved in Epistemic AI

How We Help

Problem Statement

Researchers face information overload and challenges in connecting vast and rapidly expanding biomedical knowledge, which can lead to costly mistakes and missed opportunities in drug discovery and development.

Core Technology

Artificial Intelligence

Key Differentiators

Helps researchers find hidden connections in biomedical knowledge; Aims to prevent costly mistakes and minimize missed opportunities in R&D; Streamlines drug discovery and development processes

Clinical Focus

Pulmonary Medicine

Company Info

Business Model: Platform
Founded: 2018
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: epistemic.ai/

Disease Areas

Cystic Fibrosis Mental Health Respiratory Diseases

Technologies

Knowledge GraphsGenerative AIAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

Peer-reviewed research in Nature Reviews Drug Discovery on Phase 3 trial outcomes. Platform used by academic institutions and biopharma for research and clinical trial planning.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Epistemic AI?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.